SCHEMBL4607992

SCHEMBL4607992

C[C@H]1CCCN1CCc1ccc(C2(O)CC[C@@H]3CN(Cc4ccccc4)C[C@@H]32)cc1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 15/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4609111 1.00 HRH3 (0.48) HRH3
SCHEMBL14538713 1.00 HRH3 (0.48) HRH3
SCHEMBL4624618 1.00 HRH3 (0.48) HRH3
SCHEMBL4624657 0.95 HRH3 (0.48) HRH3
SCHEMBL4624649 0.95 HRH3 (0.48) HRH3
SCHEMBL4653089 0.92 NPY1R (0.47) HRH3
SCHEMBL4653085 0.92 NPY1R (0.47) HRH3
SCHEMBL4653088 0.92 NPY1R (0.47) HRH3
SCHEMBL4608914 0.86 SLC6A3 (0.47) HRH3
SCHEMBL4651854 0.84 NPY1R (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948605-A2 MODULATORS OF THE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-07-30 EP disclosed
WO-2007061741-A2 MODULATORS OF THE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-05-31 WO disclosed